Matthew Angel, CEO of Tempest Therapeutics TPST, has filed 2 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $1M. The latest trade was on 03/24.

MA

MA

Matthew Angel

CEO and President

Company

Tempest Therapeutics TPST

First filing

23/01/13

Trades

6 trades

Buys / sales

2 / 0

12-month net buying

$1M

Last trade

03/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Tempest TherapeuticsTPST	Open-market buy	03/24	06/23	231,482 sh	$2.16	$500,001.12	No record
Tempest TherapeuticsTPST	Open-market buy	03/24	03/25	231,482 sh	$2.16	$500,001.12	No record